Point72 Asset Management’s Novartis NVS Stock Holding History

Point72 Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.4M	Buy	+283,837	New	+$43.5M	0.06%	432
2025 Q3	–	Sell	-746,706	Closed	-$91.1M	–	2570
2025 Q2	$90.4M	Sell	746,706 -335,669	-31%	-$37.8M	0.18%	134
2025 Q1	$121M	Buy	+1,082,375	New	+$115M	0.28%	78
2023 Q4	–	Sell	-181,247	Closed	-$17.5M	–	2614
2023 Q3	$18.5M	Sell	181,247 -725,039	-80%	-$73.6M	0.05%	427
2023 Q2	$91.5M	Sell	906,286 -905,061	-50%	-$90.5M	0.27%	85
2023 Q1	$167M	Buy	1,811,347 +1,105,547	+157%	+$96.6M	0.52%	27
2022 Q4	$64M	Buy	705,800 +56,100	+9%	+$4.73M	0.22%	116
2022 Q3	$49.4M	Buy	649,700 +348,500	+116%	+$28.9M	0.2%	133
2022 Q2	$25.5M	Buy	+301,200	New	+$26.4M	0.11%	257
2022 Q1	–	Sell	-152,900	Closed	-$13.4M	–	1321
2021 Q4	$13.4M	Buy	+152,900	New	+$12.7M	0.05%	434
2020 Q4	–	Sell	-794,930	Closed	-$69.1M	–	1069
2020 Q3	$69.1M	Buy	+794,930	New	+$68.9M	0.35%	61
2019 Q4	–	Sell	-541,255	Closed	-$47M	–	1160
2019 Q3	$47M	Buy	541,255 +274,355	+103%	+$24.6M	0.29%	100
2019 Q2	$24.4M	Sell	266,900 -1,330,874	-83%	-$113M	0.13%	208
2019 Q1	$138M	Sell	1,597,774 -133,221	-8%	-$10.7M	0.62%	27
2018 Q4	$133M	Buy	1,730,995 +594,608	+52%	+$46.3M	0.65%	28
2018 Q3	$87.7M	Buy	+1,136,387	New	+$84M	0.36%	68
2018 Q2	–	Sell	-517,585	Closed	-$37.5M	–	1125
2018 Q1	$37.5M	Buy	517,585 +444,832	+611%	+$33.9M	0.16%	173
2017 Q4	$5.47M	Buy	+72,753	New	+$5.49M	0.02%	574
2017 Q3	–	Sell	-129,344	Closed	-$9.67M	–	1002
2017 Q2	$9.67M	Sell	129,344 -619,046	-83%	-$43.9M	0.05%	391
2017 Q1	$49.8M	Buy	+748,390	New	+$49.9M	0.28%	89
2014 Q4	–	Sell	-23,882	Closed	-$2.01M	–	763
2014 Q3	$2.01M	Sell	23,882 -53,680	-69%	-$4.34M	0.02%	488
2014 Q2	$6.29M	Buy	+77,562	New	+$6.1M	0.04%	415

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management's NVS Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Novartis (NVS) in Q1 2026: 283,837 shares worth $43.4M. The stake represents 0.06% of the portfolio and ranks #432 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in NVS as recently as Q2 2025.

Point72 Asset Management first reported a position in NVS in Q2 2014 and has held it in 22 quarters since. The position peaked at $167M in Q1 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Point72 Asset Management held 283,837 shares of Novartis worth $43.4M as of Q1 2026.
Novartis was a new Point72 Asset Management position in Q1 2026.
Novartis made up 0.06% of Point72 Asset Management's portfolio in Q1 2026, its #432 holding.
Point72 Asset Management first reported a position in Novartis in Q2 2014 and has held it in 22 quarters since.
Point72 Asset Management's Novartis position peaked at $167M in Q1 2023.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.